ARKEMA Stock: Down 2.52% at Monday's Close, -5.73% Over the Week
Arkema's stock ended Monday's session in the red, dropping 2.52% to 50.20 euros amid a slightly declining market. The specialized chemical company confirms its technical vulnerability, with very limited trading and a deteriorated weekly performance. In the context of a generalized weakness in the sector since the beginning of the year, the stock is facing critical technical support levels as quarterly results approach.
Monday's Trading Session
The stock closed Monday at 50.20 euros, marking a decline of 2.52% from Friday's close of 51.5 euros. The CAC 40 index fell by 0.14% on the same day, to 8109.79 points, indicating a cautious context across the Paris Stock Exchange. Over seven days, Arkema has depreciated by 5.73%, erasing the modest intra-week gains from previous sessions. The trading volume remained anemic with only 0.31% of the capital traded during the day, signaling a lack of conviction from both buyers and sellers. For the year 2025, the balance remains deeply degraded with a decline of 29.57% since January 1. By comparison, the CAC 40 has increased by 9.46% over the last twelve months, widening the performance gap between the stock and the broad index. Over three months, Arkema has fallen by 13.45%, representing a significant underperformance compared to the general market. Over one year, the discount reaches 37.91%, reflecting the structural challenges faced by the chemical group for many months.
Ahead of Third Quarter 2025 Results
This weakness in the stock price comes ahead of the publication of the third-quarter 2025 results, expected at the end of the week in the results calendar from November 3 to 7. Analysts maintain close scrutiny on this file, as evidenced by Deutsche Bank's recent lowering of its price target from 76 euros to 70 euros, while maintaining a buy recommendation. The consensus of seventeen analysts stands at 1.82 buy with an average price target of 77.50 euros, suggesting a rebound potential of about 55% from current levels. Nevertheless, this wide gap between the market and analysts' estimates reflects a certain form of skepticism among institutional investors. Technically, the stock is approaching a major support at 48.49 euros, followed by a second defensive line at 47.4 euros. The chart formation suggests increasing fragility, with the stock trading below its short and medium-term moving averages.
Technical Analysis Overview
Technical analysis reveals a mixed picture. The Relative Strength Index (RSI) is at 56, positioning the stock in neutral territory with a slight underlying bullish trend. The MACD shows a line at -0.75 and a signal line at -0.98, both in negative territory, while the MACD histogram is positive at 0.23, indicating a possible attenuation of the bearish momentum. The 50-day moving average is trading at 55.30 euros, four euros above the current price, forming a dynamic resistance to the upside. The 200-day moving average is at 64.99 euros, highlighting the extent of the decline from the highs. The Bollinger Bands frame the stock between 49.58 euros (lower) and 53.92 euros (upper), placing the current price in the lower volatility zone. The beta of -0.13 indicates an inverse correlation with the general market, a particular trait for this stock.
